Sero-prevalence of unvaccinated adolescent girls susceptible to rubella virus infection seen in a tertiary care hospital of Patna, Bihar, India
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20201790Keywords:
Adolescent girls, Congenital rubella syndrome, Rubella susceptible, Seroprevalence, VaccinationAbstract
Background: Rubella infection occurring during early pregnancy results in congenital rubella syndrome (CRS). WHO estimates that worldwide more than 100,000 children are born with CRS each year and most of them are in the developing countries. For assessing population immunity against rubella, sero-surveys are generally recommended among adolescent girls and reproductive age female. In India, sero-surveys conducted by different authors have indicated that about 10-30% of adolescent females are susceptible to rubella infection. Adolescent girls are selected because they are at a critical stage of child bearing age and their immunity against Rubella infection is the particular area of interest. objective of this study was to estimate the sero-prevalence of unvaccinated adolescent girls susceptible to Rubella virus infection attending a tertiary care hospital of Patna and then accordingly counsel for vaccination.
Methods: A total 150 adolescent girls in the age group of 10-19 years who had not received MMR vaccine were included in the study. Serum IgG antibody titer for rubella was estimated by the ELISA method.
Results: A total 65.33% of the adolescent girls were found to be rubella seropositive and (34.67%) were seronegative. The urban adolescent girls had a higher seropositivity of 85.2% as compared to rural adolescent girls.
Conclusions: The study indicates that a substantial number of adolescents (34.67%) are seronegative and hence susceptible to rubella infection.
References
Burchett SK. Viral Infections. In: Cloherty JP, Eichenwald EC, Hansen AR, Stark AR (eds.), Manual of neonatal care, 7th ed, Wolters Kluwer India Pvt Ltd. 2012;619-622.
Mason WH. Rubella. In: Kliegman RM. Mason WH. Rubella. In: Kliegman RM, Stanton BF, Joseph W. St. Geme, Schor NF, Behrman RE (eds.), Nelson Textbook of pediatrics, 20th edn, Elsevier Division of Reed Elsevier India Pvt Ltd.; 2016:3085-3100.
Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, et al. Elimination of endemic Measles, Rubella, and congenital rubella syndrome from the western hemisphere: the US experience. JAMA Pediatr. 2014;168(2):148-55.
Dewan P, Gupta P. Burden of Congenital Rubella Syndrome (CRS) in India: a systematic review. Indian Pediatr. 2012;49:377-99.
Vashishtha VM, Choudhury P, Kalra A, Bose A, Thacker N, Yewale VN, et al. Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years - India, 2014 and Updates on Immunization. Indian Pediatr. 2014;51:785-800.
WHO Regional Committee for Europe resolution EUR/RC60/R12 on renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and sustained support for polio-free status in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2010.
Ramya R, Ramesh S, Ramesh J. Rubella seroprevalence among unvaccinated adolescent girls in Chennai. Int J Pharm Bio Sci. 2017;8(1):163-6.
Ramamurty N, Murugan S, Raja D, Elango V. Serosurvay of rubella in five blocks of Tamil Nadu. The Indian J Med Res. 2006;123(1):51-4.
Sharma HJ, Padbidri VS, Kapre SV, Jadhav SS, Dhere RM, Parekh SS, et al. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. The J Infect Develop Countr. 2011;5(12):874-81.
